Current Treatment Options in Oncology

Article	Citations
Role of Metastasis-Directed Therapy in Genitourinary Cancers	178
Antibody-Drug Conjugates for Melanoma and Other Skin Malignancies	122
Advances in the Pathogenesis, Diagnosis, Treatment, and Prognosis of Marginal Zone Lymphoma	91
Correction to: Antibody–Drug Conjugate Revolution in Breast Cancer: The Road Ahead	78
“Off-the-Shelf” Allogeneic CAR Cell Therapy—Neglected HvG Effect	61
Current Therapeutic Landscape in Lower Risk Myelodysplastic Syndromes	61
Whole Abdominal Radiotherapy in Bone and Soft Tissue Sarcomas: Indications, Techniques, Clinical Outcomes, and Future Directions	56
An Update on Temporal Bone Paragangliomas	55
Selecting Optimal First-Line Treatment for Microsatellite Stable and Non-Mutated RAS/BRAF Metastatic Colorectal Cancer	54
Clinical Application of Artificial Intelligence for Non-melanoma Skin Cancer	53
Current Approaches of Immune Checkpoint Therapy in Chronic Lymphocytic Leukemia	46
Combining Radiotherapy with Immunotherapy in Cervical Cancer: Where Do We Stand and Where Are We Going?	44
Management of Fatigue in Patients with Advanced Cancer	43
Options and Considerations in the Management of Peritoneal Disease in Patients with Small Bowel Neuroendocrine Tumors	43
Recent Advances in Liver Transplantation for Hepatocellular Carcinoma	40
Enhanced Photodynamic Therapy by Improved Light Energy Capture Efficiency of Porphyrin Photosensitizers	36
Approach to Localized Squamous Cell Cancer of the Esophagus	36
Small Cell Lung Cancer—An Update on Chemotherapy Resistance	35
The Role of Nursing in the Delivery of Cardio-Oncology	35
The Review of Modified Intersphincteric Resection in the Treatment of Ultra-Low Rectal Cancer	34
Advances in Targeted Therapy for Metastatic Prostate Cancer	34
Current Practice in Carcinoid Heart Disease and Burgeoning Opportunities	32
Targets Selection for Precision Therapy of Relapsed/Refractory Multiple Myeloma: the Latest Advancements	31
Perioperative Immunotherapy in Muscle-Invasive Bladder Cancer	31
Revolutionizing Breast Cancer Therapeutics: Intersecting Frontiers of Precision Medicine, Nanotechnology, and Drug Delivery Innovations	30

Regorafenib for the Treatment of Sarcoma	30
Essential Thrombocythemia in Adolescents and Young Adults: Clinical Aspects, Treatment Options and Unmet Medical Needs	29
Proposals for Clinical Trials in Chronic Myelomonocytic Leukemia	28
Telemedicine and Virtual Reality Technologies in Pain Management for Cancer Patients: A Structured Narrative Review	26
Gastric Cancer with Sarcopenia: an Area Worth Focusing On	26
Steroid Premedication and Monoclonal Antibody Therapy: Should We Reconsider?	26
Circulating Tumor DNA in Diffuse Large B-Cell Lymphoma: from Bench to Bedside?	26
Application of Engineered Dendritic Cell Vaccines in Cancer Immunotherapy: Challenges and Opportunities	25
Recognition and Management of the Long-term Effects of Cranial Radiation	25
Endocrinologic Toxicities of Cancer Therapy: Evolving Challenges and Multidisciplinary Approaches	25
A Comprehensive Review on the Role of Lurbinectedin in Soft Tissue Sarcomas	25
R0 Resection in Recurrent Gynecologic Malignancy: Pelvic Exenteration and Beyond	24
Review of Bone Metastasis in Gynecologic Malignancies: Evaluation and Treatment	24
Response Evaluation of Neoadjuvant Therapies in Sarcoma	24
Dyadic Interventions for LGBTQ+ Individuals Facing Cancer: A Narrative Review	23
Emerging DNA Methylome Targets in FLT3-ITD-Positive Acute Myeloid Leukemia: Combination Therapy with Clinically Approved FLT3 Inhibitors	23
New Therapeutic Targets in RAS Wild-type Pancreatic Cancer	23
Contemporary Review of Adenocarcinoma of the Cervix	22
Transforming a Roadblock into a Roadmap: Evolving HFSR Management From Adverse Event to Efficacy Biomarker	22
Treatment Options for Brain Metastases	22
Evolution of Treatment Strategies for Gestational Trophoblastic Neoplasia: Chemotherapy, Immunotherapy, and Molecular Targeted Therapy	22
Research Progress on Ferroptosis in Multiple Myeloma	21
Navigating PARP Inhibitor Resistance in Ovarian Cancer: Bridging Mechanistic Insights To Clinical Translation	21
Novel Estrogen Receptor-Targeted Agents for Breast Cancer	21
Neoadjuvant and Adjuvant Therapy Approaches to Gastric Cancer	21
One Size Fits Some: Approaching Rare Malignancies of the Urinary Tract	21
Approach to Stereotactic Body Radiotherapy for the Treatment of Advanced Hepatocellular Carcinoma in Patients with Child-Pugh B-7 Cirrhosis	21
Therapeutic Challenges in the Management of Serous Endometrial Intraepithelial Carcinoma (SEIC)	21
Progress in the Treatment of Small Intestine Cancer	20
Updates in Management of Malignant Pleural Mesothelioma	20
New Developments in Systemic Management for High-Risk Early-Stage Hormone-Receptor-Positive, HER2-Negative Breast Cancer	20
Understanding, Recognizing, and Managing Cancer-Related Fatigue Associated with Breast Cancer	20
Perioperative Immune Checkpoint Inhibitors for the Treatment of Locally Advanced Gastric and Gastroesophageal Junction Cancer: Current Status and Future Prospects	20
Immunotherapy in the Treatment of Undifferentiated Pleomorphic Sarcoma and Myxofibrosarcoma	19
Updates in Breast Cancer Screening and Diagnosis	19
New Insights into the Understanding of Mechanisms of Radiation-Induced Heart Disease	19
Perioperative Chemotherapy for Liver Metastasis of Colorectal Cancer: Lessons Learned and Future Perspectives	19
Advancing Bladder Cancer Management: The Role of Neoadjuvant and Adjuvant Therapies and Biomarkers in Muscle Invasive Bladder Cancer	19
Neoadjuvant Photodynamic Therapy: An Updated Therapeutic Approach for Non-Melanoma Skin Cancers	18
Re-thinking the Role of Thoracic Radiotherapy in the First-Line Treatment for Extensive-Stage Small Cell Lung Cancer	18
What are the Optimal Systemic Treatment Options for Rhabdomyosarcoma?	18
Treatment of Non-Small Cell Lung Cancer with Atypical EGFR Mutations	18
Optimal First-Line Therapy for Metastatic Adenocarcinoma of the Esophagus	17
Hypnosis for Symptom Management in Adult Cancer Patients: What is the Evidence?	17
The Role of Induction Therapy for Sinonasal Cancers	17
“When Less is More”: Paradigm Shifts in Radiation Treatment for Early-Stage Breast Cancer	17
Taxane-Associated Acute Pain Syndrome: a Review of its Features and Management	17
New Developments in Treating RAS-Mutated Metastatic Colorectal Cancer	17
Myxoid Liposarcomas: Systemic Treatment Options	17
The Role of SIRT1 in Leukemia	17

A Review on Integrating Breast Cancer Clinical Data: A Unified Platform Perspective	17
Enhancing Colorectal Cancer Treatment Through VEGF/VEGFR Inhibitors and Immunotherapy	17
Correction to: Voluntary Assisted Dying/Euthanasia: Will This Have an Impact on Cancer Care in Future Years?	16
Metastatic Castration-Resistant Prostate Cancer: Advances in Treatment and Symptom Management	16
Extent of Resection and Outcomes of Patients with Primary Malignant Brain Tumors	16
Therapeutic Management of Malignant Wounds: An Update	16
Advances in PSMA-Targeted Radionuclide Therapeutics	16
Correction to: Recent Advances in Succinate Dehydrogenase Deficient Gastrointestinal Stromal Tumor Systemic Therapies	16
Management of Functional Pancreatic Neuroendocrine Neoplasms	16
Targeting the Renin–angiotensin–aldosterone System (RAAS) for Cardiovascular Protection and Enhanced Oncological Outcomes: Review	16
HER2-Positive Metastatic Colorectal Cancer	15
Management and Treatment of Non-small Cell Lung Cancer with MET Alteration and Mechanisms of Resistance	15
RAS and Other Molecular Targets in Pancreatic Cancer: The Next Wave Is Coming	15
Measurable Residual Disease in Chronic Lymphocytic Leukemia: Current Understanding and Evolving Role in Clinical Practice	14
Advancements in Melanoma Therapies: From Surgery to Immunotherapy	14
Radiotherapy for Advanced Esophageal Cancer: from Palliation to Curation	14
Systemic Therapy for Salivary Gland Cancers: A Review of Targeted and Chemotherapeutic Approaches	14
Correction to: Surgical Management and Considerations for Patients with Localized High-Risk Prostate Cancer	14
ctDNA to Guide Treatment of Colorectal Cancer: Ready for Standard of Care?	14
Dermatofibrosarcoma Protuberans (DFSP): Diagnostics and Molecular Pathology	14
Diagnosis and Treatment of Myxoid Liposarcoma	14
Emerging Therapeutic Approaches to Pancreatic Adenocarcinoma: Advances and Future Directions	14
Immunotherapy for Metastatic Triple Negative Breast Cancer: Current Paradigm and Future Approaches	14
Systemic and Targeted Therapies in Adenoid Cystic Carcinoma	13
Systemic Management of Advanced Adrenocortical Carcinoma	13
Community Palliative Care: What are the Best Models?	13
Innovations in Cardio-oncology Resulting from the COVID-19 Pandemic	13
The Improving Outcomes in Relapsed-Refractory Diffuse Large B Cell Lymphoma: The Role of CAR T-Cell Therapy	13
Impact of PSMA PET on Prostate Cancer Management	13
Neuroendocrine Tumors: Germline Genetics and Hereditary Syndromes	13
Dermatofibrosarcoma Protuberans (DFSP): Current Treatments and Clinical Trials	12
Integrating Systemic Therapies into the Multimodality Therapy of Patients with Craniopharyngioma	12
Is There Still a Role for Transplant for Patients with Mantle Cell Lymphoma (MCL) in the Era of CAR-T Cell Therapy?	12
Management of Stage IVB Cervical Cancer Including the Role of Radiotherapy	12
Current Surgical Management for Acral Melanoma	12
The Evolving Landscape of Ovarian Cancer: Innovations in Biotechnology and Artificial Intelligence- Based Screening and Treatment	12
Nanomedicine-Based Treatments for Rare and Aggressive Ocular Cancers: Advances in Drug Delivery	12
The Role of Pharmacogenomics in Opioid Prescribing	12
Central Nervous System Prophylaxis and Treatment in Acute Leukemias	12
Advances in Immunotherapy for Breast Cancer: Up-to-date Strategies of Immune Checkpoint Inhibitors and Therapeutic Vaccines	12
Osteogenic Sarcoma of the Head and Neck: Is Chemotherapy Needed?	12
The Role of Sentinel Lymph Node Mapping in High-grade Endometrial Cancer	12
Advanced Acral Melanoma Therapies: Current Status and Future Directions	12
Treatment of Relapsed Acute Lymphocytic Leukemia in Adult Patients	11
The Future is Local: the Role of Decentralised Clinical Trials in Patients with Advanced Cancer Receiving Palliative Care	11
Current Drug Resistance Mechanisms and Treatment Options in Gastrointestinal Stromal Tumors: Summary and Update	11
Neuropathic Pain in Cancer: What Are the Current Guidelines?	11
An Update on the Clinical Status, Challenges, and Future Directions of Oncolytic Virotherapy for Malignant Gliomas	11
Interventional Cardio-Oncology: Unique Challenges and Considerations in a High-Risk Population	11
Central Nervous System Metastases in Breast Cancer	11
Prediction of Response to FDA-Approved Targeted Therapy and Immunotherapy in Acute Lymphoblastic Leukemia (ALL)	11
Antibody-Drug Conjugates in Gynecologic Cancers	11
New Molecular Insights, and the Role of Systemic Therapies and Collaboration for Treatment of Epithelioid Hemangioendothelioma (EHE)	11
The Role of Cetuximab in Non-Melanoma Skin Cancer: A Review of Clinical Evidence and Emerging Strategies	11
Immunotherapy in Early-Stage Triple-Negative Breast Cancer: Where Are We Now and Where Are We Headed?	10
The Evolving Treatment Landscape of Merkel Cell Carcinoma	10
Secondary Central Nervous System Lymphoma: Updates in Treatment and Prophylaxis Strategies	10
Candidate Biomarker of Response to Immunotherapy In Small Cell Lung Cancer	10
Relapsed Synovial Sarcoma: Treatment Options	10
Emerging Applications of CAR-T Cell Therapy in Overcoming Resistance and Expanding Targets in Hematologic Malignancies: Insights from Recent Research	10
Skin Reactions and Other Underappreciated Dermatologic Side Effects of Cancer Therapies	10
Not All Leiomyosarcomas Are the Same: How to Best Classify LMS	10
A Comprehensive Review of Cancer Drug–Induced Cardiotoxicity in Blood Cancer Patients: Current Perspectives and Therapeutic Strategies	10
Evolving Immunotherapy Strategies in Gastrointestinal Neuroendocrine Neoplasms	10
Contemporary Use of Hormonal Therapy in Endometrial Cancer: a Literature Review	10
Systemic Therapy in Advanced Pleomorphic Liposarcoma: a Comprehensive Review	10
Underlying Mechanisms of Thrombosis Associated with Cancer and Anticancer Therapies	10
New Immuno-oncology Targets and Resistance Mechanisms	10
Frontiers of Ovarian Carcinosarcoma	10
The Crying Need for a Better Response Assessment in Rectal Cancer	10
Role of Geriatric Assessment in Hematopoietic Stem Cell Transplant and Cellular Therapies	10
Advances in Understanding Drug Resistance Mechanisms and Innovative Clinical Treatments for Melanoma	10
Correction to: Metastatic Hormone–Sensitive Prostate Cancer in the Era of Doublet and Triplet Therapy	10
PAI-1 in Skin Malignancies: a Central Regulator of Tumor Progression and Therapeutic Resistance	9
Combination Immunotherapy for Mucosal Melanoma: Molecular Mechanism, Research Status, and Future Directions	9
Covalent and Non-Covalent BTK Inhibition in Chronic Lymphocytic Leukemia Treatment	9
Addressing Sexual Health in Breast Cancer Survivors: Evidence-Based Practices and Clinical Considerations	9
Updates on Therapy Options in Fit and Unfit Patients with Newly Diagnosed AML	9
Angiosarcoma: Role of Immunotherapy	9
The Use of Targeted Therapy in Pediatric Acute Lymphoblastic Leukemia: Exploring Novel Approaches and Emerging Therapies	9

Updates in Systemic Treatment of Hormone Receptor-Positive Early-Stage Breast Cancer	9
Tarlatamab-dlle: A New Hope for Patients with Extensive-Stage Small-Cell Lung Cancer	9
Desmoid Tumors: Current Perspective and Treatment	8
Targeting Glutamine Metabolism as an Attractive Therapeutic Strategy for Acute Myeloid Leukemia	8
Epithelioid Hemangioendothelioma: Treatment Landscape and Innovations for an Ultra-Rare Sarcoma	8
Immunotherapy in HPV-Related Oropharyngeal Cancers	8
Metastatic HER2-Positive Breast Cancer: Is There an Optimal Sequence of Therapy?	8
Therapeutic Cancer Vaccines for Nonmelanoma Skin Cancer	8
Surgery Matters: Progress in Surgical Management of Gastric Cancer	8
Whole Lung Irradiation in Ewing Sarcoma with Pulmonary Metastases: Critical Appraisal of Evolution, Evidence, and Future Pathways in Precision Oncology	8
Updates in Hormone Replacement Therapy for Survivors of Gynecologic Cancers	8
Advanced Mucosal Melanoma Therapies: Current Status and Future Directions	8
Neoadjuvant Short- Vs. Long-Course Radiation for Locally Advanced Rectal Cancer: How to Choose	8
Treatment of node-positive endometrial cancer: chemotherapy, radiation, immunotherapy, and targeted therapy	8
Papillary Renal Cell Carcinoma: A Review of Prospective Clinical Trials	8
Who Should Receive Immunotherapy for Advanced Gastroesophageal Cancer?	8
Systemic Anticancer Treatment Near the End of Life: a Narrative Literature Review	8
Pathogenic Mechanisms in Acute Myeloid Leukemia	8
Current Standards, Multidisciplinary Approaches, and Future Directions in the Management of Extrahepatic Cholangiocarcinoma	8
Intraperitoneal and Hyperthermic Intraperitoneal Chemotherapy for the Treatment of Ovarian Cancer	7
Targeted Therapies in the Treatment of Uterine Serous Carcinoma	7
Targeting the FGFR Pathway in Urothelial Carcinoma: the Future Is Now	7
The Role of Radiotherapy in the Management of Melanoma Brain Metastases: An Overview	7
What is the Optimal Treatment Strategy after Sarcoma R2 Surgery?	7
Therapeutic and Supportive Effects of Cannabinoids in Patients with Brain Tumors (CBD Oil and Cannabis)	7
Molecular Secrets Revealed: How Diabetes may be Paving the Way for Leukemia	7
Cardio-oncology for Pediatric and Adolescent/Young Adult Patients	7
Increasing Diversity in Head and Neck Cancer Clinical Trials	7
Oncofertility in the Age of HER2 Blockade, Immunotherapy, PARP inhibitors, CDK4/6 inhibitors and Endocrine Treatment: Unanswered Questions in Breast Cancer	7
Systemic Therapy for Solitary Fibrous Tumor	7
The Current Cardio-Oncology Landscape Across Australia	7
Neoadjuvant Chemotherapy for Adults with Osteogenic Sarcoma	7
Research Progress on the Use of Metformin in Leukemia Treatment	7
Targeted Therapy and Immunotherapy in Elderly Patients with Metastatic Colorectal Cancer	7
Cardio-Oncology and Breast Cancer Therapies	7
Beyond Serous: Treatment Options for Rare Endometrial Cancers	6
Respiratory Depression Associated with Opioids: A Narrative Review	6
Gene Mutations and Targeted Therapies of Myeloid Sarcoma	6
Recent Advances in Neoadjuvant Treatment of Anaplastic Thyroid Carcinoma: A Narrative Review	6
Trimodality Treatment of Extremity Soft Tissue Sarcoma: Where Do We Go Now?	6
Dedifferentiated Chondrosarcoma: Current Advances and Future Perspectives	6
Strategies to Assess and Manage Frailty among Patients Diagnosed with Primary Malignant Brain Tumors	6
Cardiovascular Considerations in Patients Undergoing Hematopoietic Cell Transplantation	6
Role of Radiotherapy in PCNSL within the Current Therapeutic Landscape: a Comprehensive Review	6
Research Priorities and Future Directions in Cardio-Oncology	6
Small-Molecule Compounds Boost CAR-T Cell Therapy in Hematological Malignancies	6
Research Progress of Natural Compounds from Chinese Herbal Medicine in the Treatment of Melanoma	6
Clinical Trial Data Review of the Combination FTD/TPI + Bevacizumab in the Treatment Landscape of Unresectable Metastatic Colorectal Cancer	6
Systemic Therapy for Melanoma Brain and Leptomeningeal Metastases	6
Photodynamic application in diagnostic procedures and treatment of non-melanoma skin cancers	6
Unlocking the Therapeutic Potential of Natural Polyphenols in Esophageal Cancer	6
Emerging Advances in the Molecular Landscape of Penile Cancer and Their Implications for Precision Medicine	6
Advances in Surgical Management of Malignant Tumors of the Distal Tibia	6
Antiepileptic Strategies for Patients with Primary and Metastatic Brain Tumors	6
Immunotherapy in the Fight Against Bone Metastases: A Review of Recent Developments and Challenges	6
Evaluating the Patient with Neurotoxicity after Chimeric Antigen Receptor T-cell Therapy	6
Molecular Heterogeneity in Leiomyosarcoma and Implications for Personalised Medicine	6
CDK4/6 Inhibition in the Metastatic Setting: Where Are We Headed?	6